Medical Research and Clinical Trials

Pulmonary Fibrosis Research Accelerates: ERS 2026 Signals a New Era of Treatment and Hope

• Medical Research and Clinical Trials

Pulmonary Fibrosis Research Accelerates: ERS 2026 Signals a New Era of Treatment and Hope

Evan Lee Salim September 19, 2026

Barcelona, Spain – The European Respiratory Society (ERS) International Congress 2026, held from September 5th to 9th...

Read More Read more about Pulmonary Fibrosis Research Accelerates: ERS 2026 Signals a New Era of Treatment and Hope

A Paradigm Shift in Cancer Research: Unraveling the Epigenetic Key to Colorectal Cancer Metastasis

• Medical Research and Clinical Trials

A Paradigm Shift in Cancer Research: Unraveling the Epigenetic Key to Colorectal Cancer Metastasis

Nila Kartika Wati September 19, 2026

NEW YORK, NY & CAMBRIDGE, MA – June 22, 2024 – In a significant leap forward for...

Read More Read more about A Paradigm Shift in Cancer Research: Unraveling the Epigenetic Key to Colorectal Cancer Metastasis

Akeso’s Innovative Bispecific Antibody-Drug Conjugate AK158D1 Enters Clinical Trials, Targeting Co-Expressed Solid Tumors

• Medical Research and Clinical Trials

Akeso’s Innovative Bispecific Antibody-Drug Conjugate AK158D1 Enters Clinical Trials, Targeting Co-Expressed Solid Tumors

Evan Lee Salim September 19, 2026

[City, Date] – In a significant stride for oncology drug development, Akeso, a leading biopharmaceutical company, has...

Read More Read more about Akeso’s Innovative Bispecific Antibody-Drug Conjugate AK158D1 Enters Clinical Trials, Targeting Co-Expressed Solid Tumors

Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

• Medical Research and Clinical Trials

Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

Siti Muinah September 18, 2026

New York, NY – September 18, 2026 – In a strategic move set to significantly enhance its...

Read More Read more about Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

• Medical Research and Clinical Trials

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Nana September 18, 2026

Basel, Switzerland – [Insert Date] – Roche is actively seeking to expand the therapeutic landscape for its...

Read More Read more about Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

• Medical Research and Clinical Trials

Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

Jia Lissa September 18, 2026

CAMBRIDGE, UK – A groundbreaking new treatment approach, pioneered by researchers at Cambridge, has delivered an unprecedented...

Read More Read more about Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

• Medical Research and Clinical Trials

Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

Evan Lee Salim September 18, 2026

London, UK – [Insert Date] – Vera Therapeutics is on the cusp of securing full FDA approval...

Read More Read more about Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

• Medical Research and Clinical Trials

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

Lina Hope September 18, 2026

Nottingham, UK – In a monumental leap for neuro-oncology, scientists and clinicians in Nottingham have unveiled a...

Read More Read more about Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

• Medical Research and Clinical Trials

SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

Dwi Wanna September 18, 2026

Cambridge, MA – [Insert Date of Publication] – SpliSense, a clinical-stage biopharmaceutical company, has announced the commencement...

Read More Read more about SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy

• Medical Research and Clinical Trials

AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy

Asro September 17, 2026

Seoul, Republic of Korea – A groundbreaking artificial intelligence (AI) imaging endpoint has demonstrated a remarkable ability...

Read More Read more about AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy